MAPS Trial: Matrix And Platinum Science
Public ClinicalTrials.gov record NCT00396981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Multicenter Trial Investigating Matrix 2® and GDC® Detachable Coils for the Treatment of Intracranial Saccular Aneurysms
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objectives: * To establish Target Aneurysm Recurrence (TAR) rates for Matrix 2® and GDC® Coils used for the treatment of intracranial saccular aneurysms. TAR is defined as clinically relevant recurrence resulting in: target aneurysm reintervention, rupture/re-rupture and/or death from an unknown cause. * To correlate defined angiographic endpoints with TAR rates and assess their predictive value, thereby providing a framework to establish clinically relevant endpoints for future studies. Secondary Objectives: * To evaluate device characteristics, incidence and severity of device-related adverse events, including death, neurological deterioration and changes in functional abilities. * To establish angiographic recurrence rates for Matrix 2® and GDC® Coils used for the treatment of intracranial saccular aneurysms. * To explore an experimental, quantitative and volumetric endpoint and correlate these with existing qualitative assessments.
Study identification
- NCT ID
- NCT00396981
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 626 participants
Conditions and interventions
Conditions
Interventions
- Matrix 2® coils for endovascular aneurysm occlusion Device
- GDC® coils for endovascular aneurysm occlusion Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Dec 31, 2010
- Completion
- Feb 28, 2015
- Last update posted
- Feb 16, 2016
2007 – 2015
United States locations
- U.S. sites
- 26
- U.S. states
- 21
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| Tucson Medical Center | Tucson | Arizona | 85712 | — |
| Yale-New Haven Hospital | New Haven | Connecticut | 06510 | — |
| Rush Presbyterian | Chicago | Illinois | 60640 | — |
| The Universtiy of Iowa | Iowa City | Iowa | 52242 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| University of Massachusetts Worcester | Worcester | Massachusetts | 01655 | — |
| Providence Detroit | Southfield | Michigan | 48075 | — |
| St. Joseph's Hospital | Saint Paul | Minnesota | 55104 | — |
| Saint Luke's Hospital of Kansas City | Kansas City | Missouri | 64111 | — |
| Barnes Jewish Mallinckrodt Institute of Radiology | St Louis | Missouri | 63110 | — |
| Sunrise Hospital and Medical Center | Las Vegas | Nevada | 89109 | — |
| University of New Mexico Department of Neurosurgery | Albuquerque | New Mexico | 87131 | — |
| Stony Brook Medical Center | Stony Brook | New York | 11794 | — |
| Carolina Neurosurgery & Spine Associates, PA | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Mercy Health Center | Oklahoma City | Oklahoma | 73120 | — |
| OHSU | Portland | Oregon | 97239 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Fort Sanders Regional Medical Center | Knoxville | Tennessee | 37916 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8896 | — |
| Methodist Hospital | Houston | Texas | 77030 | — |
| University of Washington Harborview Medical Center | Seattle | Washington | 98104 | — |
| Sacred Heart Providence | Spokane | Washington | 99204 | — |
| University of Wisconsin Hospital and Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00396981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00396981 live on ClinicalTrials.gov.